loading
Schlusskurs vom Vortag:
$2.65
Offen:
$2.68
24-Stunden-Volumen:
137.02K
Relative Volume:
0.54
Marktkapitalisierung:
$14.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.76M
KGV:
-0.2682
EPS:
-9.1712
Netto-Cashflow:
$-27.90M
1W Leistung:
-30.85%
1M Leistung:
-52.61%
6M Leistung:
-72.08%
1J Leistung:
-88.13%
1-Tages-Spanne:
Value
$2.46
$2.68
1-Wochen-Bereich:
Value
$2.46
$3.52
52-Wochen-Spanne:
Value
$2.46
$23.40

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name
Firmenname
Reviva Pharmaceuticals Holdings Inc
Name
Telefon
(408) 501-8881
Name
Adresse
10080 N WOLFE ROAD, CUPERTINO
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
RVPH's Discussions on Twitter

Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RVPH
Reviva Pharmaceuticals Holdings Inc
2.47 15.48M 0 -22.76M -27.90M -9.1712
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.45 121.46B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
743.82 78.93B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
702.75 43.87B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.81 42.07B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
283.80 31.65B 5.36B 287.73M 924.18M 2.5229

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-03-05 Herabstufung D. Boral Capital Buy → Hold
2025-09-29 Eingeleitet Chardan Capital Markets Buy
2023-09-20 Eingeleitet ROTH MKM Buy
2023-06-08 Eingeleitet The Benchmark Company Speculative Buy
2022-01-24 Eingeleitet H.C. Wainwright Buy

Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten

pulisher
Mar 12, 2026

Breakout Watch: How correlated is Reviva Pharmaceuticals Holdings Inc to the S P5002026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Volume Summary: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentInflation Watch & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 11, 2026

D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold By Investing.com - Investing.com Nigeria

Mar 11, 2026
pulisher
Mar 09, 2026

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears - TechStock²

Mar 09, 2026
pulisher
Mar 08, 2026

US Market Wrap: Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 07, 2026

How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reacts to inflationary pressures2025 Pullback Review & Weekly High Potential Stock Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Reviva Pharmaceuticals Announces Major Share Consolidation Plan - AD HOC NEWS

Mar 06, 2026
pulisher
Mar 06, 2026

CEO Moves: Is now the right time to enter Reviva Pharmaceuticals Holdings Inc2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Reviva Pharmaceuticals (RVPH) Downgraded to Hold by D. Boral Cap - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold - Investing.com

Mar 05, 2026
pulisher
Mar 05, 2026

Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split - TipRanks

Mar 05, 2026
pulisher
Mar 05, 2026

Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 By Investing.com - Investing.com India

Mar 05, 2026
pulisher
Mar 04, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 04, 2026
pulisher
Mar 02, 2026

RVPH PE Ratio & Valuation, Is RVPH Overvalued - Intellectia AI

Mar 02, 2026
pulisher
Mar 01, 2026

Risks Report: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channel2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 27, 2026

Rate Hike: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketShort Setup & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Feb 27, 2026
pulisher
Feb 26, 2026

Levels Update: Will Reviva Pharmaceuticals Holdings Inc benefit from sector rotationJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 22, 2026

Aug Sentiment: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflation2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn

Feb 22, 2026
pulisher
Feb 21, 2026

Trade Report: Is Reviva Pharmaceuticals Holdings Inc exposed to currency risks2025 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 21, 2026

Guidance Update: Is Reviva Pharmaceuticals Holdings Inc forming a bullish divergenceJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 21, 2026

Earnings Beat: Does Flywire Corporation stock have upside surprise potentialJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 21, 2026

Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail

Feb 21, 2026
pulisher
Feb 20, 2026

What technical signals suggest for Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Loss Report: Is ProShares Trust ProShares UltraPro MidCap400 stock forming a cup and handle2025 Volume Leaders & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 19, 2026

Market Pulse: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investment2025 Top Gainers & Weekly High Return Forecasts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Aug Spikes: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channelJuly 2025 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 19, 2026

Schizophrenia Market: Expanding Revenue Landscape to 2034 - openPR.com

Feb 19, 2026
pulisher
Feb 19, 2026

Schizophrenia Market: Expanding Revenue Landscape to 2034 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma, Minerva Neurosciences - Barchart.com

Feb 19, 2026
pulisher
Feb 16, 2026

Insider Sell: Is AMHPRG part of any ETF2025 Year in Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Feb 16, 2026
pulisher
Feb 15, 2026

Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform in a bear marketShort Setup & Smart Investment Allocation Tips - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Can Reviva Pharmaceuticals Holdings Inc. stock surprise with earnings upsideQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform tech sector in 2025Weekly Profit Report & Safe Entry Momentum Stock Tips - mfd.ru

Feb 15, 2026
pulisher
Feb 15, 2026

Why is Reviva Pharmaceuticals Holdings Inc. stock going down2025 Market Trends & Low Risk Entry Point Guides - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

How Reviva Pharmaceuticals Holdings Inc. stock compares to industry benchmarksJuly 2025 Decliners & High Accuracy Swing Entry Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

What’s Reviva Pharmaceuticals Holdings Inc.’s historical returnWeekly Profit Summary & Growth Focused Stock Pick Reports - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Growth Value: Will Quetta Acquisition Corporation Equity Right outperform its industry peersFed Meeting & Fast Entry and Exit Trade Plans - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 11, 2026

Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitJuly 2025 Price Swings & Weekly High Return Stock Opportunities - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

How sensitive is Reviva Pharmaceuticals Holdings Inc. Equity Warrant to inflationWeekly Stock Summary & Proven Capital Preservation Tips - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs in weak economy2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - mfd.ru

Feb 11, 2026
pulisher
Feb 01, 2026

Published on: 2026-02-02 10:12:16 - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Rate Hike: What is the next catalyst for TLYSMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant outperform during market ralliesWeekly Trend Recap & Daily Profit Maximizing Tips - mfd.ru

Feb 01, 2026
pulisher
Feb 01, 2026

Retail Trends: What’s the fair value of OSIS stockMarket Sentiment Review & AI Driven Price Predictions - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Aug Selloffs: Can Reviva Pharmaceuticals Holdings Inc deliver alphaWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 30, 2026

Guidance Update: Is TLRY a good stock for dollar cost averagingTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 30, 2026

RVPH Should I Buy - Intellectia AI

Jan 30, 2026
pulisher
Jan 29, 2026

Published on: 2026-01-30 02:52:59 - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 28, 2026

Breakout Watch: Does Franklin Wireless Corp have declining or rising EPSEarnings Overview Summary & Smart Investment Allocation Tips - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

Market Leaders: Will DXPRC outperform tech stocks2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 28, 2026

Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail

Jan 28, 2026

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):